Joseph E Palys

Array ( [id] => 1282772 [patent_doc_number] => 06638510 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Recombinant plasmid and a method of controlling the effects of Yersinia pestis ' [patent_app_type] => B1 [patent_app_number] => 08/302423 [patent_app_country] => US [patent_app_date] => 1994-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7524 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638510.pdf [firstpage_image] =>[orig_patent_app_number] => 08302423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3723201 [patent_doc_number] => 05670156 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Feline infectious peritonitis vaccine and method of preparation' [patent_app_type] => 1 [patent_app_number] => 8/284659 [patent_app_country] => US [patent_app_date] => 1994-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 7252 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670156.pdf [firstpage_image] =>[orig_patent_app_number] => 284659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795716 [patent_doc_number] => 05827666 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-27 [patent_title] => 'Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/288059 [patent_app_country] => US [patent_app_date] => 1994-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 29 [patent_no_of_words] => 24084 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/827/05827666.pdf [firstpage_image] =>[orig_patent_app_number] => 288059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804254 [patent_doc_number] => 05853978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Molecularly cloned acquired immunodeficiency syndrome polypeptides and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/282857 [patent_app_country] => US [patent_app_date] => 1994-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 21456 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/853/05853978.pdf [firstpage_image] =>[orig_patent_app_number] => 282857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3683294 [patent_doc_number] => 05643579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Oral vaccines' [patent_app_type] => 1 [patent_app_number] => 8/283231 [patent_app_country] => US [patent_app_date] => 1994-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14960 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643579.pdf [firstpage_image] =>[orig_patent_app_number] => 283231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622732 [patent_doc_number] => 05607851 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Process for purifying hepatitis a virus (HAV), and vaccine compositions containing hepatitis a virus' [patent_app_type] => 1 [patent_app_number] => 8/276780 [patent_app_country] => US [patent_app_date] => 1994-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1616 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/607/05607851.pdf [firstpage_image] =>[orig_patent_app_number] => 276780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3869258 [patent_doc_number] => 05824319 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Varicella-zoster virus antigen' [patent_app_type] => 1 [patent_app_number] => 8/271397 [patent_app_country] => US [patent_app_date] => 1994-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 10153 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824319.pdf [firstpage_image] =>[orig_patent_app_number] => 271397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4150660 [patent_doc_number] => 06113914 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines' [patent_app_type] => 1 [patent_app_number] => 8/193159 [patent_app_country] => US [patent_app_date] => 1994-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12718 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/113/06113914.pdf [firstpage_image] =>[orig_patent_app_number] => 193159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3920919 [patent_doc_number] => 05876724 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein' [patent_app_type] => 1 [patent_app_number] => 8/266448 [patent_app_country] => US [patent_app_date] => 1994-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 18443 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876724.pdf [firstpage_image] =>[orig_patent_app_number] => 266448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3546083 [patent_doc_number] => 05571515 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-05 [patent_title] => 'Compositions and methods for use of IL-12 as an adjuvant' [patent_app_type] => 1 [patent_app_number] => 8/265087 [patent_app_country] => US [patent_app_date] => 1994-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 10493 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/571/05571515.pdf [firstpage_image] =>[orig_patent_app_number] => 265087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3650459 [patent_doc_number] => 05639854 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Tandem synthetic HIV-1 peptides' [patent_app_type] => 1 [patent_app_number] => 8/257528 [patent_app_country] => US [patent_app_date] => 1994-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15632 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639854.pdf [firstpage_image] =>[orig_patent_app_number] => 257528 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933705 [patent_doc_number] => 05871746 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Cytotoxic T lymphocyte-inducing lipopeptides and use as vaccines' [patent_app_type] => 1 [patent_app_number] => 8/251472 [patent_app_country] => US [patent_app_date] => 1994-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 11052 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871746.pdf [firstpage_image] =>[orig_patent_app_number] => 251472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3551639 [patent_doc_number] => 05573916 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier' [patent_app_type] => 1 [patent_app_number] => 8/246278 [patent_app_country] => US [patent_app_date] => 1994-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6544 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/573/05573916.pdf [firstpage_image] =>[orig_patent_app_number] => 246278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622458 [patent_doc_number] => 05614612 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Purified gp120 compositions retaining natural conformation' [patent_app_type] => 1 [patent_app_number] => 8/240073 [patent_app_country] => US [patent_app_date] => 1994-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 33 [patent_no_of_words] => 21077 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614612.pdf [firstpage_image] =>[orig_patent_app_number] => 240073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4347075 [patent_doc_number] => 06214624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Use of perfluorocarbons as tracers in chemical compositions' [patent_app_type] => 1 [patent_app_number] => 8/234495 [patent_app_country] => US [patent_app_date] => 1994-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2063 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214624.pdf [firstpage_image] =>[orig_patent_app_number] => 234495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3800368 [patent_doc_number] => 05853725 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Prevention and treatment of retroviral disease' [patent_app_type] => 1 [patent_app_number] => 8/233508 [patent_app_country] => US [patent_app_date] => 1994-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4996 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/853/05853725.pdf [firstpage_image] =>[orig_patent_app_number] => 233508 [rel_patent_id] =>[rel_patent_doc_number] =>)